XORTX Therapeutics Inc. (XRTX)

NASDAQ: XRTX · IEX Real-Time Price · USD

1.762

-0.108 (-5.78%)

At close: Jul 2, 2024, 4:00 PM

1.810

+0.048 (2.73%)

After-hours: Jul 2, 2024, 7:55 PM EDT

XORTX Therapeutics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019
Net Income	-2.16	-7.72	-1.58	-1.28	-0.63
Depreciation & Amortization	0.14	0.06	0.01	0.02	0.02
Share-Based Compensation	0.12	0.49	0.4	0.29	0.03
Other Operating Activities	-4.69	-1.79	-3.63	0.24	0.33
Operating Cash Flow	-6.58	-8.96	-4.8	-0.73	-0.25
Capital Expenditures	-0	-0.02	0	0	0
Other Investing Activities	-0.04	-0.03	-0.03	-0.01	-0.01
Investing Cash Flow	-0.05	-0.05	-0.03	-0.01	-0.01
Share Issuance / Repurchase	0	5	18.14	0.9	0
Debt Issued / Paid	-0.07	-0.02	0	0	0
Other Financing Activities	-0.29	-0.27	1.23	-0.04	0.06
Financing Cash Flow	-0.36	4.71	19.37	0.86	0.06
Exchange Rate Effect	0	-0.14	0.2	0	0
Net Cash Flow	-6.99	-4.44	14.74	0.11	-0.2
Free Cash Flow	-6.59	-8.98	-4.8	-0.73	-0.25
Free Cash Flow Per Share	-3.32	-6.07	-4.39	-0.98	-0.42

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).